Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology


Campi R., Brookman-May S. D. , Subiela Henriquez J. D. , AKDOĞAN B. , Brausi M., Klatte T., ...Daha Fazla

EUROPEAN UROLOGY FOCUS, cilt.5, ss.1029-1057, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 5 Konu: 6
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.euf.2018.04.001
  • Dergi Adı: EUROPEAN UROLOGY FOCUS
  • Sayfa Sayıları: ss.1029-1057

Özet

Context: To date, established risk factors for prostate cancer (PCa) are limited to age, race, family history, and certain genetic polymorphisms. Despite great research efforts, available evidence on potentially modifiable risk factors is conflicting. Moreover, most studies on PCa risk factors did not consider the impact of prostate-specific antigen (PSA) testing on PCa diagnosis.